Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults

References

• Abara, W. E., Adekeye, O., Xu, J., & Rust, G. (2016). Correlates of combination antiretroviral adherence among recently diagnosed older HIV-infected adults between 50 and 64 years. AIDS & Behavior, 20(11), 2674–2681. doi:10.1007/s10461-016-1325-x
   Google Scholar
• Abara, W. E., & Heiman, H. J. (2014). The affordable care Act and low-income people living with HIV: Looking forward in 2014 and beyond. Journal of the Association of Nurses in AIDS Care, 25(6), 476–482. doi: 10.1016/j.jana.2014.05.002
   PubMed Web of Science ®Google Scholar
• Abara, W. E., Smith, L., Zhang, S., Fairchild, A. J., Heiman, H. J., & Rust, G. (2014). The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS. American Journal of Public Health, 104(11), e135–e141. doi: 10.2105/AJPH.2014.302227
   PubMed Web of Science ®Google Scholar
• Abara, W. E., Xu, J., Adekeye, O., & Rust, G. (2016). The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis. AIDS Care, 28(8), 1013–1017. doi: 10.1080/09540121.2016.1139044
   PubMed Web of Science ®Google Scholar
• Althoff, K. N., Justice, A. C., Gange, S. J., Deeks, S. G., Saag, M. S., Silverberg, M. J., … Gebo, K. A. (2010). Virologic and immunologic response to HAART, by age and regimen class. AIDS, 24(16), 2469–2479. doi: 10.1097/QAD.0b013e32833e6d14
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., &  … Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–23. doi: 10.1086/323201
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939–941. doi: 10.1086/507526
   PubMed Web of Science ®Google Scholar
• Brooks, J. T., Buchacz, K., Gebo, K. A., & Mermin, J. (2012). HIV infection and older Americans: The public health perspective. American Journal of Public Health, 102(8), 1516–1526. doi: 10.2105/AJPH.2012.300844
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2007). HIV/AIDS surveillance report, 2005 (Vol. 17, Rev ed.). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Retrieved July 28, 2016, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
   Google Scholar
• Centers for Disease Control and Prevention. (2016). Diagnoses of HIV infection among adults aged 50 years and older in the United States and dependent areas, 2010–2014. HIV Surveillance Supplemental Report, 21(2). Retrieved July 28, 2016, from http://www.cdc.gov/hiv/library/reports/surveillance/. Published May 2016.
   Google Scholar
• Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Barnighausen, T. (2014). Interventions to improve adherence to antiretroviral therapy: A rapid systematic review. AIDS, 28(S2), S187–204. doi: 10.1097/QAD.0000000000000252
   PubMed Web of Science ®Google Scholar
• Cohen, C. J., Meyers, J. L., & Davis, K. L. (2013). Association between daily antiretroviral pill burden and treatment adherence, hospitalization risk, and other healthcare utilization and costs in a US Medicaid population with HIV. BMJ Open, 3, e003028. doi: 10.1136/bmjopen-2013-003028
   PubMed Web of Science ®Google Scholar
• Daar, E. S., Tierney, C., Fischl, M. A., Sax, P. E., Mollan, K., Budhathoki, C., … Collier, A. C. (2011). Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Annals of Internal Medicine, 154, 445–456. doi: 10.7326/0003-4819-154-7-201104050-00316
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. (2008). Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 1–139. Retrieved May 10, 2015, from http://aidsinfo.nih.gov/contentfiles/adultandadolescentgl001226.pdf.
   Google Scholar
• Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical Care, 36(1), 8–27. doi: 10.1097/00005650-199801000-00004
   PubMed Web of Science ®Google Scholar
• Emlet, C. A. (2007). “You're awfully old to have this disease”: Experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist, 46(6), 781–790. doi: 10.1093/geront/46.6.781
   Web of Science ®Google Scholar
• Fielden, S. J., Rusch, M. L., Yip, B., Wood, E., Shannon, K., Levy, A. R., … Hogg, R. S. (2008). Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naıve patients started on HAART. Journal of Internal Association of Physicians in AIDS Care, 7, 238–244. doi: 10.1177/1545109708323132
   Google Scholar
• Gordon, L. L., Gharibian, D., Chong, K., & Chun, H. (2015). Comparison of HIV virologic failure rates between patients with variable adherence to three antiretroviral regimen types. AIDS Patient Care & STDS, 29(7), 384–388. doi: 10.1089/apc.2014.0165
   PubMed Web of Science ®Google Scholar
• Grabar, S., Weiss, L., & Costagliola, D. (2006). HIV infection in older patients in the HAART era. Journal of Antimicrobial Chemotherapy, 57(1), 4–7. doi: 10.1093/jac/dki411
   PubMed Web of Science ®Google Scholar
• Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet, 373(9657), 48–57. doi: 10.1016/S0140-6736(08)61697-9
   PubMed Web of Science ®Google Scholar
• Henderson, K. C., Hindman, J., Johnson, S. C., Valuck, R. J., & Kiser, J. J. (2011). Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. AIDS Patient Care STDs, 25(4), 221–228. doi: 10.1089/apc.2010.0324
   PubMed Web of Science ®Google Scholar
• Holtzman, C. W., Brady, K., & Yehia, B. R. (2015). Retention in care and medication adherence: Current challenges to antiretroviral therapy success. Drugs, 75(5), 445–454. doi: 10.1007/s40265-015-0373-2
   PubMed Web of Science ®Google Scholar
• Lewden, C., Chene, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., … Leport, C. (2007). HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. Journal of Acquired Immune Deficiency Syndrome, 46(1), 72–77.
   PubMed Web of Science ®Google Scholar
• Ma, A., Chen, D. M., Chau, F. M., & Saberi, P. (2010). Improving adherence and clinical outcomes through an HIV pharmacist’s interventions. AIDS Care, 22(10), 1189–94. doi: 10.1080/09540121003668102
   PubMed Web of Science ®Google Scholar
• McMahon, J. H., Jordan, M. R., Kelley, K., Bertagnolio, S., Hong, S. Y., Wanke, C. A., … Elliott, J. H. (2011). Pharmacy adherence measures to assess adherence to antiretroviral therapy: Review of the literature and implications for treatment monitoring. Clinical Infectious Diseases, 52(4), 493–506. doi: 10.1093/cid/ciq167
   PubMed Web of Science ®Google Scholar
• Nachega, J., Marconi, V. C., van Zyl, G. U., Gardner, E. M., Preiser, W., Hong, S. Y., … Gross, R. (2011). HIV treatment adherence, drug resistance, virologic failure: Evolving concepts. Infectious Disorders-Drug Targets, 11(2), 167–174. doi: 10.2174/187152611795589663
   PubMedGoogle Scholar
• Navarro, G., Nogueras, M. M., Segura, F., Casabona, J., Miro, J. M., Murillas, J., … Gatell, J. M. (2008). HIV-1 infected patients older than 50 years. PISCIS Cohort Study. Journal of Infectious Diseases, 57(1), 64–71.
   Google Scholar
• Parienti, J. J., Das-Douglas, M., Massari, V., Guzman, D., Deeks, S. G., Verdon, R., & Bangsberg, D. R. (2008). Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLOS One, 3(7), e2783. doi: 10.1371/journal.pone.0002783
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. doi: 10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Perno, C. F., Ceccherini-Silberstein, F., De Luca, A., Cozzi-Lepri, A., Gori, C., Cingolani, A., … Antinori, A. (2002). Virologic correlates of adherence to antiretroviral medications and therapeutic failure. Journal of Acquired Immune Deficiency Syndrome, 31S3, S118–S122. doi: 10.1097/00126334-200212153-00006
   Google Scholar
• Prejean, J., Tang, T., & Hall, I. (2013). HIV diagnoses and prevalence in the southern region of the United States, 2007–2010. Journal of Community Health, 38(3), 414–426. doi: 10.1007/s10900-012-9633-1
   PubMed Web of Science ®Google Scholar
• Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., … Ghali, W. A. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43(11), 1130–1139. doi: 10.1097/01.mlr.0000182534.19832.83
   PubMed Web of Science ®Google Scholar
• Riddler, S. A., Haubrich, R., DiRienzo, A. G., Peeples, L., Powderly, W. G., Klingman, K. L., … Mellors, J. W. (2008). Class-sparing regimens for initial treatment of HIV-1 infection. New England Journal of Medicine, 358, 2095–2106. doi: 10.1056/NEJMoa074609
   PubMed Web of Science ®Google Scholar
• Saberi, P., Dong, B. J., Johnson, M. O., Greenblatt, R. M., & Cocohoba, J. M. (2012). The impact of HIV clinical pharmacists on HIV treatment outcomes: A systematic review. Patient Prefer Adherence, 6, 297–322. doi: 10.2147/PPA.S30244
   PubMed Web of Science ®Google Scholar
• Sax, P. E., Meyers, J. L., Mugavero, M., & Davis, K. L. (2012). Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS One, 7(2), e31591. doi: 10.1371/journal.pone.0031591
   PubMed Web of Science ®Google Scholar
• Schick, V., Herbenick, D., Reece, M., Sanders, S.A., Dodge, B., Middlestadt, S.E., Fortenberry, J.D. (2010). Sexual behaviors, condom use, and sexual health of Americans over 50: Implications for sexual health promotion for older adults. Journal of Sexual Medicine, 7(s5), 315–329. doi: 10.1111/j.1743-6109.2010.02013.x
   PubMed Web of Science ®Google Scholar
• Shuter, J. (2008). Forgiveness of non-adherence to HIV-1 antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 61, 769–773. doi: 10.1093/jac/dkn020
   PubMed Web of Science ®Google Scholar
• Shuter, J, Sarlo, J. A., Kanmaz, T. J., Rode, R. A., & Zingman, B. S. (2007). HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. Journal of Acquired Immune Deficiency Syndrome, 45, 4–8. doi: 10.1097/QAI.0b013e318050d8c2
   PubMed Web of Science ®Google Scholar
• Viswanathan, S., Detels, R., Mehta, S. H., Macatangay, B. J., Kirk, G. D., & Jacobson, L. P. (2015). Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART). AIDS and Behavior, 19(4), 601–611. doi: 10.1007/s10461-014-0927-4
   PubMed Web of Science ®Google Scholar
• Weiss, A. J., Wier, L. M., Stocks, C., & Blanchard, J. (2014). Overview of emergency department visits in the United States, 2011. HCUP Statistical Brief No. 174. June 2014. Agency for Healthcare Research and Quality, Rockville, MD. Retrieved August 24, 2015, from http://www.hcup-us.ahrq.gov/reports/statbriefs/sb174-Emergency-Department-Visits-Overview.pdf.
   Google Scholar
• Wright, S. P., Verouhis, D., Gamble, G., Swedberg, K., Sharpe, N., Doughty, R. N. (2003). Factors influencing the length of hospital stay of patients with heart failure. European Journal of Heart Failure, 5(2), 201–209. doi: 10.1016/S1388-9842(02)00201-5
   PubMed Web of Science ®Google Scholar
• Wutoh, A. K., Elekwachi, O., Clarke-Tasker, V., Daftary, M., Powell, N. J., & Campusano, G. (2003). Assessment and predictors of antiretroviral adherence in older HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 33, S106–S114. doi: 10.1097/00126334-200306012-00007
   Google Scholar